Maria Carrillo
@mariacarrilloalz.bsky.social
Alzheimer's Association
ISTAART is monitoring the potential impact of the government shutdown on researchers & the dementia care community where funds & staffing capacity are critical.
Thanks to @alzassociation advocacy, NIH requested $187M increase in FY27. Bipartisan momentum in Congress is strong!
Thanks to @alzassociation advocacy, NIH requested $187M increase in FY27. Bipartisan momentum in Congress is strong!
October 2, 2025 at 5:58 PM
ISTAART is monitoring the potential impact of the government shutdown on researchers & the dementia care community where funds & staffing capacity are critical.
Thanks to @alzassociation advocacy, NIH requested $187M increase in FY27. Bipartisan momentum in Congress is strong!
Thanks to @alzassociation advocacy, NIH requested $187M increase in FY27. Bipartisan momentum in Congress is strong!
Proud to share the Alzheimer’s Association invested $112.2M in research activities over the last year — our largest single-year commitment. From gene therapy to #BrainHealth to risk reduction to AI, we’re funding bold boundary-pushing ideas. alz.org/research
#ENDALZ
#ENDALZ
Alzheimer's & Dementia Research | Alzheimer's Association
Alzheimer's and dementia research – find the latest update on research funding, grants, clinical trials and global research news.
alz.org
September 19, 2025 at 6:40 PM
Proud to share the Alzheimer’s Association invested $112.2M in research activities over the last year — our largest single-year commitment. From gene therapy to #BrainHealth to risk reduction to AI, we’re funding bold boundary-pushing ideas. alz.org/research
#ENDALZ
#ENDALZ
Today’s news from #AAIC25 marks a moment so many of us in the Alzheimer’s and dementia scientific community have long hoped for. We can now say with confidence that lifestyle interventions can protect brain health in diverse communities in the U.S.
📣Today is a turning point in what we know about brain health.
The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.
#AAIC25 alz.org/USPOINTERresults
The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.
#AAIC25 alz.org/USPOINTERresults
July 29, 2025 at 10:55 AM
Today’s news from #AAIC25 marks a moment so many of us in the Alzheimer’s and dementia scientific community have long hoped for. We can now say with confidence that lifestyle interventions can protect brain health in diverse communities in the U.S.
Reposted by Maria Carrillo
📣Today is a turning point in what we know about brain health.
The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.
#AAIC25 alz.org/USPOINTERresults
The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.
#AAIC25 alz.org/USPOINTERresults
July 28, 2025 at 7:39 PM
📣Today is a turning point in what we know about brain health.
The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.
#AAIC25 alz.org/USPOINTERresults
The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.
#AAIC25 alz.org/USPOINTERresults
“This is just the beginning,” @BillGates.bsky.social wrote in a new blog post. He’s right — Alzheimer’s and dementia research has more momentum than ever before, but now we need to go faster, earlier and bolder. That’s what @ALZAssocation’s Part the Cloud is all about.
In a new blog post, @billgates.bsky.social shares his hope for—and commitment to—the fight to #ENDALZ, highlighting his support for the Association’s Part the Cloud initiative, which funds high-risk, high-reward clinical trials aimed at accelerating scientific breakthroughs. gatesnot.es/4edi98q
gatesnot.es
June 18, 2025 at 3:51 PM
“This is just the beginning,” @BillGates.bsky.social wrote in a new blog post. He’s right — Alzheimer’s and dementia research has more momentum than ever before, but now we need to go faster, earlier and bolder. That’s what @ALZAssocation’s Part the Cloud is all about.
Congratulations to the recipients of the @alzassociation Part the Cloud Gene Targeting Challenge. This funding program is focused on gene editing, with the aim of developing potential therapies that change the expression of a gene at some level. bit.ly/4l8yEVx
Alzheimer's Association Part the Cloud Grants $5 Million to Develop Gene Targeting Treatments
Through the Alzheimer's Association, the Part the Cloud grants support development of innovative gene targeting treatments for Alzheimer's and dementia.
bit.ly
June 13, 2025 at 4:33 PM
Congratulations to the recipients of the @alzassociation Part the Cloud Gene Targeting Challenge. This funding program is focused on gene editing, with the aim of developing potential therapies that change the expression of a gene at some level. bit.ly/4l8yEVx
The myths and fabrications persistently shared by the Health and Human Services Secretary aren’t just disappointing – they’re dangerous. See below for the facts and for our full statement in response to the Secretary’s comments.
❌ FALSE: “For 20 years…we were directing Alzheimer’s research to one hypothesis. And any other hypotheses were shut down.” - Sec. Kennedy
Over the last decade, less than 14% of new National Institutes of Health (NIH) Alzheimer’s projects focused on amyloid beta as the therapeutic target. 🧵(1/4)
Over the last decade, less than 14% of new National Institutes of Health (NIH) Alzheimer’s projects focused on amyloid beta as the therapeutic target. 🧵(1/4)
May 16, 2025 at 4:11 PM
The myths and fabrications persistently shared by the Health and Human Services Secretary aren’t just disappointing – they’re dangerous. See below for the facts and for our full statement in response to the Secretary’s comments.
Reposted by Maria Carrillo
It was a privilege to deliver one of the keynotes at today’s #CNDSymposium Day2 @iusm-medneuro.bsky.social alongside @elizabethhead.bsky.social @mariacarrilloalz.bsky.social. Congrats to @wilcocklab.bsky.social for the amazing 2 days of science 🤓💪🏼
April 14, 2025 at 10:23 PM
It was a privilege to deliver one of the keynotes at today’s #CNDSymposium Day2 @iusm-medneuro.bsky.social alongside @elizabethhead.bsky.social @mariacarrilloalz.bsky.social. Congrats to @wilcocklab.bsky.social for the amazing 2 days of science 🤓💪🏼
@alzassociation.bsky.social CEO Dr Joanne Pike and the World Dementia Council rising chair is closing a fantastic day of discussions to accelerate innovation and deliver change! #ENDALZ
March 25, 2025 at 3:57 PM
@alzassociation.bsky.social CEO Dr Joanne Pike and the World Dementia Council rising chair is closing a fantastic day of discussions to accelerate innovation and deliver change! #ENDALZ
Reposted by Maria Carrillo
Reposted by Maria Carrillo
📣 Join the "The Basics: Glymphatic System – A Focus on the Role of Sleep" @istaart.bsky.social webinar to learn the fundamental mechanisms of the glymphatic system and the critical role of #sleep in its function. 🧠🧼💤
📆 Register alz-org.zoom.us/webinar/regi...
@claireandre.bsky.social #EndAlz
📆 Register alz-org.zoom.us/webinar/regi...
@claireandre.bsky.social #EndAlz
March 5, 2025 at 2:44 PM
📣 Join the "The Basics: Glymphatic System – A Focus on the Role of Sleep" @istaart.bsky.social webinar to learn the fundamental mechanisms of the glymphatic system and the critical role of #sleep in its function. 🧠🧼💤
📆 Register alz-org.zoom.us/webinar/regi...
@claireandre.bsky.social #EndAlz
📆 Register alz-org.zoom.us/webinar/regi...
@claireandre.bsky.social #EndAlz
Observations from today’s confirmation hearing for the director of the NIH: 1. bipartisan support for addressing dementia was on full display & 2. harmful myths about Alzheimer’s research continue to persist and that needs to stop. Our full statement: bit.ly/4bql5Nv
Bipartisan Support for Alzheimer’s and Dementia Research During Senate HELP Committee
Read the Alzheimer's Association statement on the Senate HELP Committee hearing for the National Institutes of Health (NIH) director nominee.
bit.ly
March 6, 2025 at 12:19 AM
Observations from today’s confirmation hearing for the director of the NIH: 1. bipartisan support for addressing dementia was on full display & 2. harmful myths about Alzheimer’s research continue to persist and that needs to stop. Our full statement: bit.ly/4bql5Nv
So honored to be a part of this first symposium @IU @wilcocklab.bsky.social @malutansey.bsky.social to #ENDALZ
We encourage everyone who can to join us for the first annual Center for Neurodegenerative Disorders Symposium. Sunday April 13th for our community event and / or Monday April 14th for our scientific event. This is a free event and we have a virtual option! Scan the QR code to register!
March 4, 2025 at 5:42 PM
So honored to be a part of this first symposium @IU @wilcocklab.bsky.social @malutansey.bsky.social to #ENDALZ
Reposted by Maria Carrillo
Join us this week in San Juan #PuertoRico for Human Amyloid Imaging Conference #HAI2025 😊 Excited to participate in a panel discussion on disparities in neuroimaging & AD research, organized by the ISTAART Neuroimaging PIA and Diversity & Disparities PIA (Prof Interest Area)🤩
Love Languages GIF
ALT: Love Languages GIF
media.tenor.com
January 12, 2025 at 3:18 PM
Join us this week in San Juan #PuertoRico for Human Amyloid Imaging Conference #HAI2025 😊 Excited to participate in a panel discussion on disparities in neuroimaging & AD research, organized by the ISTAART Neuroimaging PIA and Diversity & Disparities PIA (Prof Interest Area)🤩
Reposted by Maria Carrillo
What an incredible time period to be working on updated appropriate use criteria for amyloid and tau PET! Awesome group to work with...I learned so much🧠
alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
@alzassociation.bsky.social @snm-mi.bsky.social
alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
@alzassociation.bsky.social @snm-mi.bsky.social
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
INTRODUCTION
The Alzheimer's Association and the Society of Nuclear Medicine and Molecular Imaging convened a multidisciplinary workgroup to update appropriate use criteria (AUC) for amyloid positro.....
alz-journals.onlinelibrary.wiley.com
January 8, 2025 at 1:09 PM
What an incredible time period to be working on updated appropriate use criteria for amyloid and tau PET! Awesome group to work with...I learned so much🧠
alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
@alzassociation.bsky.social @snm-mi.bsky.social
alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
@alzassociation.bsky.social @snm-mi.bsky.social
Reposted by Maria Carrillo
🚨 ISTAART Voices is back! 🎉
Join us as we chat with scientists about their groundbreaking work from the Alzheimer’s & Dementia journal family.
Tune in on your favorite podcast platforms, or visit alz.org/ISTAARTpodcasts! 🎧
Join us as we chat with scientists about their groundbreaking work from the Alzheimer’s & Dementia journal family.
Tune in on your favorite podcast platforms, or visit alz.org/ISTAARTpodcasts! 🎧
January 8, 2025 at 3:52 PM
🚨 ISTAART Voices is back! 🎉
Join us as we chat with scientists about their groundbreaking work from the Alzheimer’s & Dementia journal family.
Tune in on your favorite podcast platforms, or visit alz.org/ISTAARTpodcasts! 🎧
Join us as we chat with scientists about their groundbreaking work from the Alzheimer’s & Dementia journal family.
Tune in on your favorite podcast platforms, or visit alz.org/ISTAARTpodcasts! 🎧